Brief: Richter Announces FY Pharma Sales HUF 914 Billion
27/02/2026 05:12
Feb 27 (Reuters) - Richter Gedeon Vegyeszeti Gyar Nyrt GDRB.BU: RICHTER - FY PHARMA SALES HUF 914 BILLION RICHTER - FY EBIT HUF 292.85 BILLION RICHTER - FY REVENUE HUF 928,962 MILLION RICHTER - 2026 GUIDANCE: HIGH-SINGLE-DIGIT (HSD) GROWTH BOTH REVENUES AND CLEAN EBIT (BOTH CER) RICHTER - FY REVENUE HUF 928.96 BILLION Source text: https://tinyurl.com/msn742a4 Further company coverage: GDRB.BU ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Richter Gedeon Vegyeszeti Gyar Nyrt
See all newsAI in Hungary could unlock productivity gains of €15 billion, McKinsey says
Brief: Hungary's Richter and Hetero announce cooperation for development of semaglutide injection
Brief: Hungary's Richter and Acrux agree to license transdermal Estradiol spray for Australia
Brief: Hungary's Richter Says 2026 Guidance Fully Reiterated High-Single-Digit Growth In Revenues And Clean EBIT (At Constant Exchange Rates)
Brief: Hungary's Richter says European Commission granted approval for Tuyory, its biosimilar to Tocilizumab